Strategic Global Advisors LLC bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 8,246 shares of the company’s stock, valued at approximately $3,215,000.
Several other institutional investors also recently modified their holdings of HCA. Nomura Asset Management Co. Ltd. grew its position in shares of HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the last quarter. Sunbelt Securities Inc. grew its holdings in HCA Healthcare by 171.7% in the 1st quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares in the last quarter. Liberty Wealth Management LLC bought a new position in HCA Healthcare during the 4th quarter worth $1,905,000. Arrowstreet Capital Limited Partnership boosted its position in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares during the period. Finally, Sei Investments Co. increased its position in HCA Healthcare by 27.5% during the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after acquiring an additional 100,764 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of brokerages have issued reports on HCA. Wall Street Zen lowered shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Barclays reduced their price target on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating on the stock in a research report on Monday, July 27th. UBS Group cut their target price on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Sanford C. Bernstein reaffirmed a “market perform” rating on shares of HCA Healthcare in a research report on Wednesday, July 15th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $462.64.
HCA Healthcare Stock Down 0.6%
NYSE:HCA opened at $426.36 on Thursday. The firm has a market capitalization of $92.31 billion, a PE ratio of 14.27, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52. The stock’s 50-day simple moving average is $399.36 and its 200 day simple moving average is $442.21.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping analysts’ consensus estimates of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The business’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.84 earnings per share. On average, analysts anticipate that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.
HCA Healthcare Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is 10.45%.
About HCA Healthcare
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
